Literature DB >> 8350052

Antibodies against major histocompatibility complex class II antigens directly inhibit the growth of T cells infected with Theileria parva without affecting their state of activation.

M Eichhorn1, T D Prospero, V T Heussler, D A Dobbelaere.   

Abstract

We have analyzed the effect of antibodies (Abs) directed against major histocompatibility complex (MHC) class II Abs on the proliferation of Theileria parva-infected (Tpi) T cells. Anti-MHC class II Abs exert a direct effect on Tpi T cells causing an acute block in their proliferation. The inhibition does not involve apoptosis and is also entirely reversible. The rapid arrest of DNA synthesis caused by anti-MHC class II Abs is not due to interference with the state of activation of the T cells since the transcriptional activator NF-kappa B remains activated in arrested cells. In addition, interleukin 2 (IL-2), IL-2R, and c-myc gene expression are also unaffected. By analyzing the cell-cycle phase distribution of inhibited cells, it could be shown that cells in all phases of the cell cycle are inhibited. The signal transduction pathway that results in inhibition was shown to be independent of protein kinase C and extracellular Ca2+. Tyrosine kinase inhibitors, however, partly reduced the level of inhibition and, conversely, phosphatase inhibitors enhanced it. The possible relevance of this phenomenon in other systems is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350052      PMCID: PMC2191146          DOI: 10.1084/jem.178.3.769

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  IL-2 can enhance the cyclosporin A-mediated inhibition of Theileria parva-infected T cell proliferation.

Authors:  M Eichhorn; N S Magnuson; R Reeves; R O Williams; D A Dobbelaere
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

2.  Growth inhibition of human T cells by antibodies recognizing the T cell antigen receptor complex.

Authors:  J B Breitmeyer; S O Oppenheim; J F Daley; H B Levine; S F Schlossman
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

3.  Inhibition by anti-HLA class II monoclonal antibodies of monocyte-dependent T cell proliferation induced by monoclonal antibody OKT3.

Authors:  G Ruggiero; C Manzo; S Fontana; G Scala; G Pirozzi; S Ferrone; S Zappacosta
Journal:  Eur J Immunol       Date:  1987-11       Impact factor: 5.532

4.  Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen.

Authors:  G A Bishop; G Haughton
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

5.  The role of I-A/E molecules in B lymphocyte activation. I. Inhibition of lipopolysaccharide-induced responses by monoclonal antibodies.

Authors:  S Forsgren; G Pobor; A Coutinho; M Pierres
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

6.  Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes.

Authors:  J C Cambier; M K Newell; L B Justement; J C McGuire; K L Leach; Z Z Chen
Journal:  Nature       Date:  1987 Jun 18-24       Impact factor: 49.962

7.  Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules.

Authors:  M Merćep; J A Bluestone; P D Noguchi; J D Ashwell
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

8.  Cell growth cycle block of T cell hybridomas upon activation with antigen.

Authors:  J D Ashwell; R E Cunningham; P D Noguchi; D Hernandez
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

9.  Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.

Authors:  H Golding; F A Robey; F T Gates; W Linder; P R Beining; T Hoffman; B Golding
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  IL-2-mediated T cell proliferation in humans is blocked by a monoclonal antibody directed against monomorphic determinants of HLA-DR antigens.

Authors:  A Moretta; R S Accolla; J C Cerottini
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

View more
  2 in total

1.  Monocytes control gamma/delta T-cell responses by a secreted product.

Authors:  A J Okragly; M Hanby-Flarida; C L Baldwin
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

2.  Stage-specific requirement of a mitogen-activated protein kinase by Trypanosoma brucei.

Authors:  Ingrid B Müller; Debora Domenicali-Pfister; Isabel Roditi; Erik Vassella
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.